dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Janjigian, Yelena |
dc.contributor.author | Van Cutsem, Eric |
dc.contributor.author | Muro, Kei |
dc.contributor.author | Al-Batran, Salah-Eddin |
dc.contributor.author | Hyung, Woo Jin |
dc.contributor.author | Tabernero Caturla, Josep |
dc.contributor.author | Wainberg, Zev |
dc.date.accessioned | 2022-09-06T11:20:26Z |
dc.date.available | 2022-09-06T11:20:26Z |
dc.date.issued | 2022-06 |
dc.identifier.citation | Janjigian YY, Van Cutsem E, Muro K, Wainberg Z, Al-Batran SE, Hyung WJ, et al. MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer. Futur Oncol. 2022 Jun;18(20):2465–2473. |
dc.identifier.issn | 1479-6694 |
dc.identifier.uri | https://hdl.handle.net/11351/8033 |
dc.description | Quimioterapia; Durvalumab; Cáncer gástrico |
dc.language.iso | eng |
dc.publisher | Future Medicine |
dc.relation.ispartofseries | Future Oncology;18(20) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Estómac - Càncer - Tractament |
dc.subject | Quimioteràpia combinada |
dc.subject.mesh | Stomach Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols |
dc.subject.mesh | Neoadjuvant Therapy |
dc.title | MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.2217/fon-2022-0093 |
dc.subject.decs | neoplasias gástricas |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | protocolos de quimioterapia antineoplásica combinada |
dc.subject.decs | tratamiento neoadyuvante |
dc.relation.publishversion | https://doi.org/10.2217/fon-2022-0093 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Janjigian YY] Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. [Van Cutsem E] Department of Gastroenterology/Digestive Oncology, University Hospitals Leuven & KU Leuven, Leuven, 3000, Belgium. [Muro K] Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, 464-8681, Japan. [Wainberg Z] Department of Gastrointestinal Medical Oncology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90404, USA. [Al-Batran SE] Institute of Clinical Cancer Research, Krankenhaus Nordwest, University Cancer Center, Frankfurt, 60488, Germany. [Hyung WJ] Department of Surgery, Yonsei University College of Medicine, Seoul, 03722, South Korea. [Tabernero J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. IOB-Quiron, UVic-UCC, Barcelona, 08035, Spain |
dc.identifier.pmid | 35535555 |
dc.identifier.wos | 000804192000001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |